Home >  Investors Relations >  CryoLife Initiates Enrollment in PROACT Xa Clinical Trial

CryoLife to Participate in the UBS Global Healthcare Virtual Conference

May 18, 2021 at 8:35 AM EDT

ATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021. The Company's virtual fireside chat is scheduled to begin at 11:00 a.m. ET.  

A live webcast of the virtual fireside chat will be accessible through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website. 

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:  


CryoLife  

Gilmartin Group LLC 

D. Ashley Lee 

Brian Johnston / Lynn Lewis 

Executive Vice President, Chief Financial Officer
and Chief Operating Officer       

Phone: 631-807-1986 
investors@cryolife.com 

Phone: 770-419-3355


 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-to-participate-in-the-ubs-global-healthcare-virtual-conference-301293517.html

SOURCE CryoLife, Inc.